Results: 428

Neuroprotective potential of polydatin against motor abnormalities and dopaminergic neuronal loss in rotenone induced Parkinson model

Int. j. morphol; 36 (2), 2018
Among the neurodegenerative disorders, Parkinson disease (PD) is ranked as second most common. The pathological hallmark is selective degeneration of the dopaminergic neurons in the nigro-striatal regions of brain with appearance of the Lewy bodies. Present study explores the neuro-protective potential o...

Decisions about deep brain stimulation therapy in Parkinson's disease

Arq. neuropsiquiatr; 76 (6), 2018
ABSTRACT Parkinson's disease can be treated surgically in patients who present with motor complications such as fluctuations and dyskinesias, or medically-refractory disabling tremor. In this review, a group of specialists formulated suggestions for a preoperative evaluation protocol after reviewing the ...

Impulse control and related disorders in Parkinson's disease

Arq. neuropsiquiatr; 76 (6), 2018
ABSTRACT Neuropsychiatric disorders are common among patients with Parkinson's disease and may appear in any stage of the disease. However, these disorders often go undiagnosed and receive insufficient treatment. Observations in recent years have revealed that dopamine replacement therapy may lead to the...

Revisión de trastornos psiquiátricos en enfermedad de Parkinson (EP): a propósito de un caso

Psiquiatr. salud ment; 35 (1/2), 2018
La Enfermedad de Parkinson se inicia generalmente en las personas entre los 50 y 60 años, La mayoría de los pacientes de Parkinson se encuentran en situación de doble vulnerabilidad: vejez y discapacidad. El objetivo del tratamiento es reducir la velocidad de progresión de la enfermedad, controlar lo...

Estimulación cerebral profunda en enfermedad de Parkinson

Rev. méd. Chile; 146 (5), 2018
Background: Deep brain stimulation is an essential therapeutic tool in Parkinson's disease. Aim: To assess the results of a series of patients with Parkinson's disease treated with micro-electrode guided subthalamic nucleus stimulation. Material and Methods: Twenty patients with idiopathic Parkinson's ...

Circulating levels of neurotrophic factors are unchanged in patients with Parkinson's disease

Arq. neuropsiquiatr; 76 (5), 2018
ABSTRACT There is great evidence linking neurotrophic factor (NF) dysfunction with Parkinson's disease (PD) pathophysiology. This study was conducted to evaluate plasma levels of NFs and their possible associations with clinical symptoms in PD. For this purpose, 40 PD patients and 25 controls were subjec...

Translation, linguistic and cultural adaptation, reliability and validity of the Radboud Oral Motor Inventory for Parkinson's Disease - ROMP questionnaire

Arq. neuropsiquiatr; 76 (5), 2018
ABSTRACT Objective: To translate and linguistically and culturally adapt to Brazilian Portuguese, and verify the reliability and validity of the Radboud Oral Motor Inventory for Parkinson's Disease (ROMP). Methods: The ROMP was translated and retranslated, and the instrument reliability was verified by...

Fadiga e prática de atividade física na doença de Parkinson: revisão de literatura

Introdução: A doença de Parkinson é a segunda doença neurodegenerativa mais prevalente na população mundial, com maior incidência nos idosos. A fadiga corresponde a um dos sintomas não motores mais frequentes na doença de Parkinson e prejudica a qualidade de vida desses pacie...

The daily lives of people with Parkinson's disease

Rev. bras. enferm; 71 (2), 2018
ABSTRACT Objective: To understand the daily lives of people with Parkinson's disease. Method: Qualitative research, using as methodological and theoretical referential the Grounded Theory and Symbolic Interactionism, respectively. The in-depth interview was conducted with 30 people with Parkinson's dis...